Racial and geographic issues in gastroesophageal reflux disease

American Journal of Gastroenterology

Volumn 103, Issue 11, 2008, Pages 2669-2680

  Sharma, Prateek ^a,e   Wani, Sachin ^a   Romero, Yvonne ^b   Johnson, David ^c   Hamilton, Frank ^d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE;

BARRETT ESOPHAGUS; CANCER RISK; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; ETHNIC DIFFERENCE; GASTROESOPHAGEAL REFLUX; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; RISK FACTOR; TREATMENT RESPONSE;

CONTINENTAL POPULATION GROUPS; GASTROESOPHAGEAL REFLUX; GEOGRAPHY; HUMANS;

EID: 55349126386     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02089.x     Document Type: Review

References (110)

1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 20 quiz 1943.
2. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006 101 : 2128 38.
3. Wahlqvist P, Reilly MC, Barkun A. Systematic review: The impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Ther 2006 24 : 259 72.
4. Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2005 54 : 710 7.
5. El-Serag HB. Time trends of gastroesophageal reflux disease: A systematic review. Clin Gastroenterol Hepatol 2007 5 : 17 26.
6. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006 4 : 398 407.
7. Pan G, Xu G, Ke M, et al. Epidemiologic study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chin J Dig Dis 2000 1 : 2 8.
8. Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: A population-based study. Aliment Pharmacol Ther 2002 16 : 2081 8.
9. Wong WM, Lai KC, Lam KF, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: A population-based study. Aliment Pharmacol Ther 2003 18 : 595 604.
10. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Asan-si, Korea. Am J Gastroenterol 2005 100 : 747 53.
11. Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol 2005 20 : 26 9.
12. Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol 2005 100 : 759 65.
13. Nouraie M, Radmard AR, Zaer-Rezaii H, et al. Hygiene could affect GERD prevalence independently: A population-based study in Tehran. Am J Gastroenterol 2007 102 : 1353 60.
14. Pourshams Aletaha N, Nouraie SM, et al. Gastroesophageal reflux disease in Iranian general population: The prevalence and risk factors. Gastroenterology 2007 132 : A 485.
15. Sperber AD, Halpern Z, Shvartzman P, et al. Prevalence of GERD symptoms in a representative Israeli adult population. J Clin Gastroenterol 2007 41 : 457 61.
16. Khuroo MS, Mahajan R, Zargar SA, et al. Prevalence of peptic ulcer in India: An endoscopic and epidemiological study in urban Kashmir. Gut 1989 30 : 930 4.
17. Kang JY, Tay HH, Yap I, et al. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastroenterol 1993 16 : 70 3.
18. Yeh C, Hsu CT, Ho AS, et al. Erosive esophagitis and Barrett's esophagus in Taiwan: A higher frequency than expected. Dig Dis Sci 1997 42 : 702 6.
19. Yeom JS, Park HJ, Cho JS, et al. Reflux esophagitis and its relationship to hiatal hernia. J Korean Med Sci 1999 14 : 253 6.
20. Furukawa N, Iwakiri R, Koyama T, et al. Proportion of reflux esophagitis in 6010 Japanese adults: Prospective evaluation by endoscopy. J Gastroenterol 1999 34 : 441 4.
21. Inamori M, Togawa J, Nagase H, et al. Clinical characteristics of Japanese reflux esophagitis patients as determined by Los Angeles classification. J Gastroenterol Hepatol 2003 18 : 172 6.
22. Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M, et al. Lower esophagus in dyspeptic Iranian patients: A prospective study. J Gastroenterol Hepatol 2003 18 : 315 21.
23. Rosaida MS, Goh KL. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: A prospective, endoscopy based study. Eur J Gastroenterol Hepatol 2004 16 : 495 501.
24. Toruner M, Soykan I, Ensari A, et al. Barrett's esophagus: Prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol 2004 19 : 535 40.
25. Hongo M, Shoji T. Epidemiology of reflux disease and CLE in East Asia. J Gastroenterol 2003 38 (Suppl. 15 25 30.
26. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005 100 : 1923 8.
27. Goh KL. Prevalence of and risk factors for Helicobacter pylori infection in a multi-racial dyspeptic Malaysian population undergoing endoscopy. J Gastroenterol Hepatol 1997 12 : S29 35.
28. Wong WM, Lam SK, Hui WM, et al. Long-term prospective follow-up of endoscopic oesophagitis in southern Chinese - prevalence and spectrum of the disease. Aliment Pharmacol Ther 2002 16 : 2037 42.
29. Lee JI, Park H, Jung HY, et al. Prevalence of Barrett's esophagus in an urban Korean population: A multicenter study. J Gastroenterol 2003 38 : 23 7.
30. Ahmed HH, Mudawi HM, Fedail SS. Gastro-oesophageal reflux disease in Sudan: A clinical endoscopic and histopathological study. Trop Gastroenterol 2004 25 : 135 8.
31. Novis BH, Bank S, Marks IN, et al. Upper gastro-intestinal fibre-optic endoscopy. A 3-year study at Groote Schuur Hospital. S Afr Med J 1974 48 : 857 61.
32. Segal I. The gastro-oesophageal reflux disease complex in sub-Saharan Africa. Eur J Cancer Prev 2001 10 : 209 12.
33. Bassey OO, Eyo EE, Akinhanmi GA. Incidence of hiatus hernia and gastro-oesophageal reflux in 1030 prospective barium meal examinations in adult Nigerians. Thorax 1977 32 : 356 9.
34. Chiocca JC, Olmos JA, Salis GB, et al. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: A nationwide population-based study. Aliment Pharmacol Ther 2005 22 : 331 42.
35. Moraes-Filho JP, Chinzon D, Eisiq JN, et al. Prevalence of heartburn and gastroesophageal reflux disease in the urban Brazilian population. Arq Gastroenterol 2005 42 : 122 7.
36. Csendes A, Valenzuela J, Becker P, et al. Prevalence of esophageal and gastrointestinal symptoms in Chilean adults. Rev Med Chil 1989 117 : 146 9.
37. Andreollo NA, Michelino MU, Brandalise NA, et al. Incidence and epidemiology of Barrett's epithelium at the Gastrocentro-UNICAMP. Arq Gastroenterol 1997 34 : 22 6.
38. Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Can Med Assoc J 1982 126 : 46 8.
39. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995 27 : 67 70.
40. Deltenre Melot C, van Wilder Ph, et al. Heartburn in Belgium: A population-based epidemiological study. Gastroenterology 1998 114 (Suppl. A100 1.
41. Valle C, Broglia F, Pistorio A, et al. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999 44 : 1848 52.
42. Terry P, Lagergren J, Wolk A, et al. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer 2000 38 : 186 91.
43. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, et al. Symptoms of gastro-oesophageal reflux: Prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004 19 : 95 105.
44. Mohammed I, Nightingale P, Trudgill NJ. Risk factors for gastro-oesophageal reflux disease symptoms: A community study. Aliment Pharmacol Ther 2005 21 : 821 7.
45. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report. Scand J Gastroenterol 2005 40 : 275 85.
46. Johnsen R, Bernersen B, Straume B, et al. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991 302 : 749 52.
47. Borch K, Jonsson KA, Petersson F, et al. Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: Relations to symptomatology and life-style. Dig Dis Sci 2000 45 : 1322 9.
48. Voutilainen M, Sipponen P, Mecklin JP, et al. Gastroesophageal reflux disease: Prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000 61 : 6 13.
49. Todd JA, Johnston DA, Dillon JF. The changing spectrum of gastroesophageal reflux disease. Eur J Cancer Prev 2002 11 : 215 9.
50. Mantynen T, Farkkila M, Kunnamo I, et al. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: A 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol 2002 97 : 2524 9.
51. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: An endoscopic study. Gastroenterology 2005 129 : 1825 31.
52. Malfertheiner P, Lind T, Willich S, et al. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: Report from the ProGORD study. Gut 2005 54 : 746 51.
53. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 1976 21 : 953 6.
54. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 1992 102 : 1259 68.
55. Locke GR, 3rd., Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 : 1448 56.
56. Locke GR 3rd., Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999 106 : 642 9.
57. El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 2004 126 : 1692 9.
58. Hirota WK, Loughney TM, Lazas DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data. Gastroenterology 1999 116 : 277 85.
59. el-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998 43 : 327 33.
60. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990 99 : 918 22.
61. Cameron AJ, Lomboy CT. Barrett's esophagus: Age, prevalence, and extent of columnar epithelium. Gastroenterology 1992 103 : 1241 5.
62. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002 123 : 461 7.
63. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003 125 : 1670 7.
64. Wani S, Rastogi A, Bansal A, et al. Symptom profiles and endoscopic findings in African-American patients with gastroesophageal reflux disease. Gastroenterology 2007 132 (Suppl. A 161.
65. el-Serag HB, Sonnenberg A. Associations between different forms of gastro-oesophageal reflux disease. Gut 1997 41 : 594 9.
66. Spechler SJ, Jain SK, Tendler DA, et al. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2002 16 : 1795 800.
67. Bersentes K, Fass R, Padda S, et al. Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. Dig Dis Sci 1998 43 : 1038 41.
68. Abrams JA, Fields S, Lightdale CJ, et al. Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol 2008 6 : 30 4.
69. Neumann CS, Cooper BT. Ethnic differences in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 1999 11 : 735 9.
70. Ford AC, Forman D, Reynolds PD, et al. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol 2005 162 : 454 60.
71. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: The long and short of it all. Dig Dis Sci 2004 49 : 237 42.
72. Rajendra S, Ackroyd R, Murad S, et al. Human leucocyte antigen determinants of susceptibility to Barrett's oesophagus in Asians - a preliminary study. Aliment Pharmacol Ther 2005 21 : 1377 83.
73. Ang TL, Fock KM, Ng TM, et al. A comparison of the clinical, demographic and psychiatric profiles among patients with erosive and non-erosive reflux disease in a multi-ethnic Asian country. World J Gastroenterol 2005 11 : 3558 61.
74. Silber W. The prevalence, course and management of some benign oesophageal diseases in the Black population. The Groote Schuur Hospital experience. S Afr Med J 1983 63 : 957 9.
75. Mason RJ, Bremner CG. The columnar-lined (Barrett's) oesophagus in black patients. S Afr J Surg 1998 36 : 61 2.
76. Mohammed I, Cherkas LF, Riley SA, et al. Genetic influences in gastro-oesophageal reflux disease: A twin study. Gut 2003 52 : 1085 9.
77. Haruma K. Review article: Influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004 20 (Suppl. 8 40 4.
78. Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997 112 : 1442 7.
79. Haruma K, Hamada H, Mihara M, et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: Case-control study in Japan. Helicobacter 2000 5 : 24 9.
80. Raghunath AS, Hungin AP, Wooff D, et al. Systematic review: The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment Pharmacol Ther 2004 20 : 733 44.
81. Kinoshita Y, Kawanami C, Kishi K, et al. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997 41 : 452 8.
82. Yoshiike N, Kaneda F, Takimoto H. Epidemiology of obesity and public health strategies for its control in Japan. Asia Pac J Clin Nutr 2002 11 (Suppl. 8 S727 31.
83. Lim SL, Goh WT, Lee JM, et al. Changing prevalence of gastroesophageal reflux with changing time: Longitudinal study in an Asian population. J Gastroenterol Hepatol 2005 20 : 995 1001.
84. Pandolfino JE, Zhang QG, Ghosh SK, et al. Transient lower esophageal sphincter relaxations and reflux: Mechanistic analysis using concurrent fluoroscopy and high-resolution manometry. Gastroenterology 2006 131 : 1725 33.
85. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006 367 : 2086 100.
86. Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: A challenge to esophagogastric junction integrity. Gastroenterology 2006 130 : 639 49.
87. Lam SK, Hasan M, Sircus W, et al. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980 21 : 324 8.
88. Cryer B, Feldman M. Racial differences in gastric function among African Americans and Caucasian Americans: Secretion, serum gastrin, and histology. Proc Assoc Am Physicians 1996 108 : 481 9.
89. Wong WM, Lai KC, Hui WM, et al. Pathophysiology of gastroesophageal reflux diseases in Chinese - role of transient lower esophageal sphincter relaxation and esophageal motor dysfunction. Am J Gastroenterol 2004 99 : 2088 93.
90. Ho KY, Kang JY. Reflux esophagitis patients in Singapore have motor and acid exposure abnormalities similar to patients in the western hemisphere. Am J Gastroenterol 1999 94 : 1186 91.
91. Hu WH, Wong NY, Lai KC, et al. Normal 24-hour ambulatory proximal and distal gastroesophageal reflux parameters in Chinese. Hong Kong Med J 2002 8 : 168 71.
92. Vega KJ, Rabaa E, Jamal MM. Lower esophageal sphincter pressure and distal esophageal body function between Hispanic Americans and non-Hispanic whites are equivalent. J Clin Gastroenterol 2007 41 : 141 4.
93. Robinson M. Review article: The pharmacodynamics and pharmacokinetics of proton pump inhibitors - overview and clinical implications. Aliment Pharmacol Ther 2004 20 (Suppl. 6) : 1 10.
94. Lim PW, Goh KL, Wong BC. CYP2C19 genotype and the PPIs - focus on rabeprazole. J Gastroenterol Hepatol 2005 20 (Suppl. S22 8.
95. Kawamura M, Ohara S, Koike T, et al. The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism. Aliment Pharmacol Ther 2003 17 : 965 73.
96. Egan LJ, Myhre GM, Mays DC, et al. CYP2C19 pharmacogenetics in the clinical use of proton-pump inhibitors for gastro-oesophageal reflux disease: Variant alleles predict gastric acid suppression, but not oesophageal acid exposure or reflux symptoms. Aliment Pharmacol Ther 2003 17 : 1521 8.
97. Wong WM, Lai KC, Hui WM, et al. Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2004 19 : 455 62.
98. Degl' Innocenti A, Guyatt GH, Wiklund I, et al. The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Health Qual Life Outcomes 2005 3 : 4.
99. Pascoe GC. Patient satisfaction in primary health care: A literature review and analysis. Eval Program Plann 1983 6 : 185 210.
100. Wyatt SB, Winters KP, Dubbert PM. Overweight and obesity: Prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 2006 331 : 166 74.
101. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity, and gastroesophageal reflux disease. Gut 2006 56 : 756 62.
102. Rey E, Moreno-Elola-Olaso C, Artalejo FR, et al. Association between weight gain and symptoms of gastroesophageal reflux in the general population. Am J Gastroenterol 2006 101 : 229 33.
103. Lagergren J, Bergstrom R, Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut 2000 47 : 26 9.
104. Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003 98 : 940 8.
105. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis. Am J Gastroenterol 2006 101 : 2619 28.
106. Long AE, Prewitt TE, Kaufman JS, et al. Weight-height relationships among eight populations of West African origin: The case against constant BMI standards. Int J Obes Relat Metab Disord 1998 22 : 842 6.
107. Fernandez JR, Heo M, Heymsfield SB, et al. Is percentage body fat differentially related to body mass index in Hispanic Americans, African Americans, and European Americans? Am J Clin Nutr 2003 77 : 71 5.
108. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: A meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998 22 : 1164 71.
109. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 100 : 190 200.
110. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002 97 : 1888 95.